Abstract
The description of cyclophotocoagulation does not mention controlled cyclophotocoagulation, which—in contrast to conventional cyclophotocoagulation—does not have side effects. The mechanism of action is the real-time dosing control of each individual effect, so that overdosing or underdosing, and especially “pop” effects, can be mostly avoided. The procedure not only reduces the production of aqueous humor in the anterior chamber but also improves the uveoscleral outflow. Controlled cyclophotocoagulation achieves a good pressure lowering effect, has a low complication profile, and is simple to perform; facts that are borne out not only by our own clinical experience. It is a non-invasive procedure, and almost no reports of pain have been recorded. The procedure was developed by Professor Preusner of the eye hospital at the University Medical Center of the Johannes Gutenberg University Mainz.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
